MedTrace Logo

China Monogenic Diabetes Registry

NCT07492004 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-03-25

No results posted yet for this study

Summary

This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to:

Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution

Participants will:

* Enroll in the monogenic diabetes registry via mobile application or web-based platform
* Undergo molecular genetic testing to establish a definitive diagnosis

Conditions

  • Neonatal Diabetes
  • Monogenic Diabetes
  • Maturity Onset Diabetes of the Young

Interventions

OTHER

No Interventions

No Interventions

Sponsors & Collaborators

  • Tianjin Medical University General Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-28
Primary Completion
2030-07-31
Completion
2030-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07492004 on ClinicalTrials.gov